News About: Pharm. Affairs
Would the once-a-week injector ‘Trulicity’ alter the once-a-day pattern?
While GLP-1 analogues have attracted interests of the industry due to obesity control as well as the hypoglycemic function, the injection-type GLP-1 analogue ‘Trulicity (generic name: dulaglutide),’ which can be injec...
Who will be the winner in the new drug challenge of the KRW 2.6 trillion xerophthalmia market?
Aim for the xerophthalmia market. Domestic pharmaceutical companies have made challenges to new xerophthalmia drugs in the global market.
Although no product has been commercialized, products of the pharmaceutical co...
Lilly has been approved for the obesity-control diabetes drub ‘Trulicity’ in the domestic market
It is observed that Lilly Korea will launch the new diabetes treatment with the GLP-1 analogue type.
The drug type is the obesity-control diabetes drug, which has been highly interested by the current market.
The ty...
Galderma gava a priot notice to adopt a gel-type facial flushing treatment in the Korean market
A spreading-type facial flushing treatment is expected to be adopted in the Korean market.
According to the industry concerned on the 29th, Galderma has been working on a procedure to acquire a domestic approval of i...
The international pharmaceutical market will be expanded to $1.3 trillion in 2018
It is anticipated that the international pharmaceutical market will be increased to $1.3 trillion by 2018.
At the ‘GloPharmEx’ inauguration ceremony held at Intercontinental Hotel, COEX on the 27th, President Kyung-w...
Implications for the industry to learn as a half of the global top 10 drugs are specialty drugs
It has been noticed that the trend of the global new drug development is analyzed to certainly move from traditional drugs to specialty drugs, such as antibodies.
According to the recent report published by Yuanta Se...
The Supreme Court decision over Baraclude established a ground for the patent acceptance of usage and volume
The hepatitis type B treatment ‘Baraclude’ patent suit, won by Jeil Pharm on the last 21st, has attracted interests of the pharmaceutical industry as founding a ground for pharmaceutical products to be accepted in usa...
The KRW 150 billion antidepressant market has fallen into chaos with emergence of Pristiq
The domestic antidepressant treatment market is estimated to be approximately KRW 150 billion in accordance to the end of the last year,
The most frequently used SSRI-type products are ‘Prozac (fluoxetine),’ ‘Zoloft(...
Celltrion won the patent suit and accelerated global commercialization over its breast cancer treatmentAs Celltrion won the formulation patent suit over the original product of the breast cancer biosimilar ‘Herzuma,’ the company is now able to actively take procedures for its dom...
|
Will the KRW 400 billion NSAIDs market experience fluctuations?
The NSAIDs (non-steroidal anti-inflammatory drugs) market, forming the annually KRW 400 billion market, is fluctuating. The industry is now paying attention to the fluctuation.
Changes have already been noticed in th...
